Authors

• Filippo de Marinis (ORCID: https://orcid.org/0000-0002-1118-5536)
• Iván Díaz-Padilla
• Kenneth A. Locke
• Michael Schenker (ORCID: https://orcid.org/0000-0003-2645-6391)
• Sun Min Lim (ORCID: https://orcid.org/0000-0001-7694-1593)
• Gustavo Dix Junqueira Pinto (ORCID: https://orcid.org/0000-0002-3743-6380)
• Solange Peters (ORCID: https://orcid.org/0000-0002-0412-7143)
• Zsolt Szíjgyártó (ORCID: https://orcid.org/0000-0002-1086-4094)
• C.S. Fuentes
• Neda Stjepanovic (ORCID: https://orcid.org/0000-0002-5688-4728)
• Jin Seok Ahn (ORCID: https://orcid.org/0000-0002-2880-6730)
• Giuseppe Lo Russo (ORCID: https://orcid.org/0000-0003-3224-2728)
• Ana Laura Ortega Granados (ORCID: https://orcid.org/0000-0002-5727-3371)
• Elena Buss

Institutions

• Yonsei University (KR)
• Severance Hospital (KR)
• Samsung Medical Center (KR)
• Centre Hospitalier Universitaire Vaudois (CH)
• Hospital de Câncer de Barretos (BR)
• GlaxoSmithKline (United States) (US)
• Complejo Hospitalario de Jaén (ES)
• MRC Biostatistics Unit (GB)
• Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
• European Institute of Oncology (IT)
• Sungkyunkwan University (KR)

Publication Details

Journal

JTO Clinical and Research Reports

Published

2025-09-04

DOI

https://doi.org/10.1016/j.jtocrr.2025.100900

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

0.00